Schedule of Restricted Stock Units Grant (Details) - $ / shares |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Aug. 31, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Share-Based Payment Arrangement [Abstract] | |||
| Number of units outstanding beginning | 39,524 | ||
| Weighted average grant date fair value outstanding ending | $ 2.10 | ||
| Number of units, granted | 96,114 | ||
| Weighted average grant date fair value, granted | $ 1.61 | ||
| Number of units, exercised and converted to common shares | (5,682) | (39,524) | |
| Weighted average grant date fair value, exercised and converted to common shares | $ 1.82 | $ 4.40 | $ 2.10 |
| Number of units, forfeited | |||
| Weighted average grant date fair value, forfeited | |||
| Number of units outstanding beginning | 90,432 | ||
| Weighted average grant date fair value outstanding ending | $ 1.43 | ||
| Number of units exercisable | 5,682 | ||
| Weighted average grant date fair value exercisable | $ 4.40 | ||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options exercisable non vested number. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options exercises in period weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options non vested exercisable weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|